Litcius/Paper detail

Introducing a pyrazolopyrimidine as a multi-tyrosine kinase inhibitor, using multi-QSAR and docking methods

Asrin Bahmani, Hamid Tanzadehpanah, Neda Hosseinpour Moghadam, Massoud Saidijam

2020Molecular Diversity27 citationsDOI

Topics & Concepts

Quantitative structure–activity relationshipDocking (animal)RegorafenibComputational biologyChemistryDrug discoveryReceptor tyrosine kinaseBinding siteStereochemistryBiologyKinaseBiochemistryCancerColorectal cancerGeneticsMedicineNursingSynthesis and biological activityComputational Drug Discovery MethodsHER2/EGFR in Cancer Research
Introducing a pyrazolopyrimidine as a multi-tyrosine kinase inhibitor, using multi-QSAR and docking methods | Litcius